HRT Financial’s NantHealth, Inc NH Stock Holding History

HRT Financial’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,380	Closed	-$19K	–	858
2018 Q4	$19K	Buy	+2,380	New	+$41.7K	﹤0.01%	554

Other funds holding NH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WCM

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

HRT Financial's NH Position: Q1 2019 in Review

HRT Financial sold out of NantHealth, Inc (NH) in Q1 2019, closing a stake of 2,380 shares — an estimated $19K sold.

HRT Financial first reported a position in NH in Q4 2018 and held it in 1 quarter. The position peaked at $19K in Q4 2018. 42 funds tracked by Wall St. Rank hold NH as of Q1 2019.

HRT Financial reported no remaining NantHealth, Inc position as of Q1 2019 after selling out during the quarter.
HRT Financial sold 2,380 NantHealth, Inc shares in Q1 2019, an estimated $19K.
HRT Financial first reported a position in NantHealth, Inc in Q4 2018 and held it in 1 quarter.
HRT Financial's NantHealth, Inc position peaked at $19K in Q4 2018.
42 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2019.

Based on HRT Financial's 13F filing for Q1 2019, filed 14 May 2019.